Hyaluronic Acid Products Market

Hyaluronic Acid Products Market: Three Cycle Injection Products Segment to Remain Dominant Throughout the Forecast Period: Global Industry Analysis 2012 - 2016 and Opportunity Assessment 2017 - 2027

Ask The Analyst Customization Available Request Methodology

Innovations are fuelling process and product development in the global hyaluronic acid products market

There is ample opportunity for both incumbents and new entrants in hyaluronic acid products market as there is a continuous search for more comfortable, advanced, and efficient products. Product safety and efficacy are the key concerns that need to be addressed in hyaluronic acid products market. Hyaluronic acid products have common side-effects such as skin inflammation, reddening, pain, and itching that often remain for extended periods of time. Therefore, process innovation in product formation or manufacturing of new dosage that increases patient convenience is critical in hyaluronic acid products market. Developing the product manufacturing process and making it cost-efficient with greater efficacy would naturally attract more customers to opt for hyaluronic acid treatments.

Combination products are a notable trend to tap into in the global hyaluronic acid products market

The hyaluronic acid products market is quite mature in developed regions such as Europe where patients have the awareness of such treatments and are able to afford them as well. There is a saturation of hyaluronic acid products in hyaluronic acid products market with changes in the molecular weight. A recent trend witnessed is that of combination products and the pipelines of key stakeholders in hyaluronic acid products market have a combo of corticosteroid and hyaluronic acid based injections. This game-changing concoction provides the pain relieving effect of corticosteroids with the long-lasting influence of hyaluronic acids that can sometimes last for half a year. The three-cycle injection product segment is the largest in the Western Europe hyaluronic acid products market and is expected to cross US$ 430 million by end 2027.

Next-gen injections are on the anvil in the global hyaluronic acid products market

Intra-articular hyaluronic acid or IAHA injection manufacturers are investing heavily in R&D and trying to strengthen their competitive position in the IAHA market with a combination of hyaluronic acid products. On account of its excellent physiochemical properties, it is very easy to merge hyaluronic acid products with other pharmaceuticals such as corticosteroids. For e.g. – Anika’s product CINGAL is considered a viscoelastic supplement for synovial fluid in human joints and a third-gen viscosupplementation product. However, this product is not yet approved for use by US regulatory authorities. Companies in the North America hyaluronic acid products market would be advised to focus their attention on the three cycle injection products segment as it is anticipated to grow with the highest CAGR of 8.1% from 2017 to 2027.

hyaluronic acid products market

High costs can stifle prospects of the hyaluronic acid products market in price-sensitive emerging economies

Products in hyaluronic acid products market are highly efficient but a majority of patients are unable to afford them because of their high cost. Single-injection and three-injection cycles in particular are premium priced products making it challenging for them to appeal to customers in emerging markets with a limited disposable income. The high price is usually because of the difficulties in manufacturing hyaluronic acid. Another constraint is the numerous side-effects witnessed after undergoing hyaluronic acid treatment.

Alternative treatments inhibit unencumbered growth of the hyaluronic acid products market

Alternative treatments have become popular in recent times. In the case of osteoporosis, over-the-counter medication or even COX-2 inhibitors can be provided if the pain is unbearable. Physical therapies and steroid injection deliver temporary pain relief and decrease inflammation. Sometimes arthroscopic surgery, joint replacement, or osteotomy are recommended for osteoporosis.

Cohesive report structure that flows in a logical format

Hyaluronic acid is a glycosaminoglycan widely distributed throughout neural, epithelial, and connective tissue. The report titled ‘Hyaluronic Acid Products Market: Global Industry Analysis 2012 – 2016 and Opportunity Assessment 2017 – 2027’ sheds light on the different factors poised to impact growth of the hyaluronic acid products market during the course of the forecast period. The report begins with a succinct yet comprehensive executive summary for a first-glance that encapsulates the market overview, analysis, and recommendations. An introduction to the global hyaluronic acid products market that consists of the definition and taxonomy follows. An in-depth assessment of the macroeconomic factors such as regulations, opportunity analysis, revenue growth, and the global value chain is par for the course. The historical analysis of the hyaluronic acid products market for the period 2012- 2026 is compared and contrasted with the decadal forecast to present a complete picture of the present and future prospects in the hyaluronic acid products market.

The successive chapters highlight the value forecast of the hyaluronic acid products market across the studied regions. The crucial market dynamics along with an impact analysis of the drivers and restraints that influence the hyaluronic acid products market are provided herein. A forecast of the hyaluronic acid products market for the various market segments and sub-segments for the regions is mentioned. The regional sections conclude with a market attractiveness index along with their relevance and impact on the overall hyaluronic acid products market.

Hyaluronic Acid Products Market: Taxonomy

Product Type

Application

Region

  • Single Cycle Injection Products

  • Three Cycle Injection Products

  • Five Cycle Injection Products

  • Osteoarthritis

  • Ophthalmic

  • Dermal Fillers

  • Vesicoureteral Reflux

  • North America

  • Latin America

  • Western Europe

  • Eastern Europe

  • Japan

  • Asia Pacific Ex. Japan

  • MEA

A crucial chapter of the hyaluronic acid products market report focuses on the competitive landscape. The section touches on the market structure, competition intensity map on the basis of the taxonomy, and an exhaustive competition dashboard featuring prominent companies actively involved in the hyaluronic acid products market. The leading companies have been profiled with information on their product portfolio, business strategies, recent developments, and financials. Another section of the hyaluronic acid products market report delivers a revenue forecast for market segments within specific regions. The informative report ends with a brief dive into the research methodology adopted to arrive at accurate estimations of the hyaluronic acid products market with an index of assumptions and acronyms used throughout the report.

Flowchart of the research methodology

Future Market Insights has devised a robust research methodology that can be considered an industry benchmark. The research methodology is highly systematic, multi-pronged in its approach, and includes both primary as well as secondary research to determine leading products, players, market size, applications, distributors, industry connotations, and others. The data extracted from primary and secondary research undergoes several layers of validation and cross-verification. The team of experts have many years of experience in diverse domains and their recommendations can be very useful indeed. The primary and secondary data is combined with analyst opinions’ via a triangulation method to deliver an unbiased report on the hyaluronic acid products market. To ensure fool-proof accuracy, information is only gathered from authoritative sources such as industry publications, government websites, trade journals, company statements, and press releases. Lastly, the data is thoroughly scrutinized with the help of advanced company tools to glean all the qualitative and quantitative insights of the hyaluronic acid products market.

Hyaluronic Acid Products Market Reports - Table of Contents

1. Executive Summary

1.1. Market Overview

1.2. Market Analysis

1.3. FMI Analysis and Recommendations

1.4. Wheel of Fortune

2. Market Introduction

2.1. Market Taxonomy

2.2. Market Definition

2.3. Hyaluronic Acid Products Market Overview

3. Hyaluronic Acid Products Market View Point

3.1. Macro-Economic Factors

3.2. Opportunity Analysis

3.3. Reimbursement Guide for Hyaluronic Acid Products

3.4. Key Regulations

4. North America Hyaluronic Acid Products Market Analysis 2012–2016 and Forecast 2017–2027

4.1. Introduction

4.2. Regional Market Dynamics

4.2.1. Drivers

4.2.2. Restraints

4.2.3. Trends

4.3. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016

4.3.1. U.S.

4.3.2. Canada

4.4. Market Size (US$ Mn) Forecast By Country, 2017-2027

4.4.1. U.S.

4.4.2. Canada

4.5. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016

4.5.1. Single Cycle Injection Products

4.5.2. Three Cycle Injection Products

4.5.3. Five Cycle Injection Products

4.6. Market Size (US$ Mn) Forecast By Product Type, 2017-2027

4.6.1. Single Cycle Injection Products

4.6.2. Three Cycle Injection Products

4.6.3. Five Cycle Injection Products

4.7. Historical Market Size (US$ Mn) Analysis By Application, 2012-2016

4.7.1. Osteoarthritis

4.7.2. Ophthalmic

4.7.3. Dermal Fillers

4.7.4. Vesicoureteral Reflux

4.8. Market Size (US$ Mn) Forecast By Application, 2017-2027

4.8.1. Osteoarthritis

4.8.2. Ophthalmic

4.8.3. Dermal Fillers

4.8.4. Vesicoureteral Reflux

4.9. Drivers and Restraints: Impact Analysis

4.10.Market Attractiveness Analysis

4.10.1. By Country

4.10.2. By Product Type

4.10.3. By Application

4.11. Key Representative Market Participants

4.12. Key Participants Market Presence (Intensity Map)

5. Latin America Hyaluronic Acid Products Market Analysis 2012–2016 and Forecast 2017–2027

5.1. Introduction

5.2. Regional Market Dynamics

5.2.1. Drivers

5.2.2. Restraints

5.2.3. Trends

5.3. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016

5.3.1. Brazil

5.3.2. Mexico

5.3.3. Rest of Latin America

5.4. Market Size (US$ Mn) Forecast By Country, 2017-2027

5.4.1. Brazil

5.4.2. Mexico

5.4.3. Rest of Latin America

5.5. Regional Market Dynamics

5.5.1. Drivers

5.5.2. Restraints

5.5.3. Trends

5.6. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016

5.6.1. Single Cycle Injection Products

5.6.2. Three Cycle Injection Products

5.6.3. Five Cycle Injection Products

5.7. Market Size (US$ Mn) Forecast By Product Type, 2017-2027

5.7.1. Single Cycle Injection Products

5.7.2. Three Cycle Injection Products

5.7.3. Five Cycle Injection Products

5.8. Historical Market Size (US$ Mn) Analysis By Application, 2012-2016

5.8.1. Osteoarthritis

5.8.2. Ophthalmic

5.8.3. Dermal Fillers

5.8.4. Vesicoureteral Reflux

5.9. Market Size (US$ Mn) Forecast By Application, 2017-2027

5.9.1. Osteoarthritis

5.9.2. Ophthalmic

5.9.3. Dermal Fillers

5.9.4. Vesicoureteral Reflux

5.10. Drivers and Restraints: Impact Analysis

5.11. Market Attractiveness Analysis

5.11.1. By Country

5.11.2. By Product Type

5.11.3. By Application

5.12. Key Representative Market Participants Key Participants Market Presence (Intensity Map)

6. Western Europe Hyaluronic Acid Products Market Analysis 2012–2016 and Forecast 2017–2027

6.1. Introduction

6.2. Regional Market Dynamics

6.2.1. Drivers

6.2.2. Restraints

6.2.3. Trends

6.3. Historical Market Size (US$ Mn) and Volume Analysis By Country, 2012-2016

6.3.1. Germany

6.3.2. United Kingdom

6.3.3. France

6.3.4. Italy

6.3.5. Spain

6.3.6. Nordics

6.3.7. Rest of Western Europe

6.4. Market Size (US$ Mn) and Volume Forecast By Country, 2017-2027

6.4.1. Germany

6.4.2. United Kingdom

6.4.3. France

6.4.4. Italy

6.4.5. Spain

6.4.6. Nordics

6.4.7. Rest of Western Europe

6.5. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016

6.5.1. Single Cycle Injection Products

6.5.2. Three Cycle Injection Products

6.5.3. Five Cycle Injection Products

6.6. Market Size (US$ Mn) Forecast By Product Type, 2017-2027

6.6.1. Single Cycle Injection Products

6.6.2. Three Cycle Injection Products

6.6.3. Five Cycle Injection Products

6.7. Historical Market Size (US$ Mn) Analysis By Application, 2012-2016

6.7.1. Osteoarthritis

6.7.2. Ophthalmic

6.7.3. Dermal Fillers

6.7.4. Vesicoureteral Reflux

6.8. Market Size (US$ Mn) Forecast By Application, 2017-2027

6.8.1. Osteoarthritis

6.8.2. Ophthalmic

6.8.3. Dermal Fillers

6.8.4. Vesicoureteral Reflux

6.9. Drivers and Restraints: Impact Analysis

6.10. Market Attractiveness Analysis

6.10.1. By Country

6.10.2. By Product Type

6.10.3. By Application

6.11. Key Representative Market Participants

6.12. Key Participants Market Presence (Intensity Map)

7. Eastern Europe Hyaluronic Acid Products Market Analysis 2012–2016 and Forecast 2017–2027

7.1. Introduction

7.2. Regional Market Dynamics

7.2.1. Drivers

7.2.2. Restraints

7.2.3. Trends

7.3. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016

7.3.1. Russia

7.3.2. Poland

7.3.3. Rest of Eastern Europe

7.4. Market Size (US$ Mn) Forecast By Country, 2017-2027

7.4.1. Russia

7.4.2. Poland

7.4.3. Rest of Eastern Europe

7.5. Regional Market Dynamics

7.5.1. Drivers

7.5.2. Restraints

7.5.3. Trends

7.6. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016

7.6.1. Single Cycle Injection Products

7.6.2. Three Cycle Injection Products

7.6.3. Five Cycle Injection Products

7.7. Market Size (US$ Mn) Forecast By Product Type, 2017-2027

7.7.1. Single Cycle Injection Products

7.7.2. Three Cycle Injection Products

7.7.3. Five Cycle Injection Products

7.8. Historical Market Size (US$ Mn) Analysis By Application, 2012-2016

7.8.1. Osteoarthritis

7.8.2. Ophthalmic

7.8.3. Dermal Fillers

7.8.4. Vesicoureteral Reflux

7.9. Market Size (US$ Mn) Forecast By Application, 2017-2027

7.9.1. Osteoarthritis

7.9.2. Ophthalmic

7.9.3. Dermal Fillers

7.9.4. Vesicoureteral Reflux

7.10. Drivers and Restraints: Impact Analysis

7.11. Market Attractiveness Analysis

7.11.1. By Country

7.11.2. By Product Type

7.11.3. By Application

7.12. Key Representative Market Participants

7.13. Key Participants Market Presence (Intensity Map)

8. Japan Hyaluronic Acid Products Market Analysis 2012–2016 and Forecast 2017–2027

8.1. Introduction

8.2. Regional Market Dynamics

8.2.1. Drivers

8.2.2. Restraints

8.2.3. Trends

8.3. Regional Market Dynamics

8.3.1. Drivers

8.3.2. Restraints

8.3.3. Trends

8.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016

8.4.1. Single Cycle Injection Products

8.4.2. Three Cycle Injection Products

8.4.3. Five Cycle Injection Products

8.5. Market Size (US$ Mn) Forecast By Product Type, 2017-2027

8.5.1. Single Cycle Injection Products

8.5.2. Three Cycle Injection Products

8.5.3. Five Cycle Injection Products

8.6. Historical Market Size (US$ Mn) Analysis By Application, 2012-2016

8.6.1. Osteoarthritis

8.6.2. Ophthalmic

8.6.3. Dermal Fillers

8.6.4. Vesicoureteral Reflux

8.7. Market Size (US$ Mn) Forecast By Application, 2017-2027

8.7.1. Osteoarthritis

8.7.2. Ophthalmic

8.7.3. Dermal Fillers

8.7.4. Vesicoureteral Reflux

8.8. Drivers and Restraints: Impact Analysis

8.9. Market Attractiveness Analysis

8.9.1. By Product Type

8.9.2. By Application

8.10. Key Representative Market Participants

8.11. Key Participants Market Presence (Intensity Map)

9. Asia Pacific Excluding Japan Hyaluronic Acid Products Market Analysis 2012–2016 and Forecast 2017–2027

9.1. Introduction

9.2. Regional Market Dynamics

9.2.1. Drivers

9.2.2. Restraints

9.2.3. Trends

9.3. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016

9.3.1. China

9.3.2. India

9.3.3. Australia and New Zealand

9.3.4. ASEAN

9.3.5. Rest of APEJ

9.4. Market Size (US$ Mn) Forecast By Country, 2017-2027

9.4.1. China

9.4.2. India

9.4.3. Australia and New Zealand

9.4.4. ASEAN

9.4.5. Rest of APEJ

9.5. Regional Market Dynamics

9.5.1. Drivers

9.5.2. Restraints

9.5.3. Trends

9.6. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016

9.6.1. Single Cycle Injection Products

9.6.2. Three Cycle Injection Products

9.6.3. Five Cycle Injection Products

9.7. Market Size (US$ Mn) Forecast By Product Type, 2017-2027

9.7.1. Single Cycle Injection Products

9.7.2. Three Cycle Injection Products

9.7.3. Five Cycle Injection Products

9.8. Historical Market Size (US$ Mn) Analysis By Application, 2012-2016

9.8.1. Osteoarthritis

9.8.2. Ophthalmic

9.8.3. Dermal Fillers

9.8.4. Vesicoureteral Reflux

9.9. Market Size (US$ Mn) Forecast By Application, 2017-2027

9.9.1. Osteoarthritis

9.9.2. Ophthalmic

9.9.3. Dermal Fillers

9.9.4. Vesicoureteral Reflux

9.10. Drivers and Restraints: Impact Analysis

9.11. Market Attractiveness Analysis

9.11.1. By Country

9.11.2. By Product Type

9.11.3. By Application

9.12. Key Representative Market Participants

9.13. Key Participants Market Presence (Intensity Map)

10. Middle East and Africa Hyaluronic Acid Products Market Analysis 2012–2016 and Forecast 2017–2027

10.1. Introduction

10.2. Regional Market Dynamics

10.2.1. Drivers

10.2.2. Restraints

10.2.3. Trends

10.3. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016

10.3.1. GCC Countries

10.3.2. South Africa

10.3.3. Rest of Middle East and Africa

10.4. Market Size (US$ Mn) Forecast By Country, 2017-2027

10.4.1. GCC Countries

10.4.2. South Africa

10.4.3. Rest of Middle East and Africa

10.5. Regional Market Dynamics

10.5.1. Drivers

10.5.2. Restraints

10.5.3. Trends

10.6. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016

10.6.1. Single Cycle Injection Products

10.6.2. Three Cycle Injection Products

10.6.3. Five Cycle Injection Products

10.7. Market Size (US$ Mn) Forecast By Product Type, 2017-2027

10.7.1. Single Cycle Injection Products

10.7.2. Three Cycle Injection Products

10.7.3. Five Cycle Injection Products

10.8. Historical Market Size (US$ Mn) Analysis By Application, 2012-2016

10.8.1. Osteoarthritis

10.8.2. Ophthalmic

10.8.3. Dermal Fillers

10.8.4. Vesicoureteral Reflux

10.9. Market Size (US$ Mn) Forecast By Application, 2017-2027

10.9.1. Osteoarthritis

10.9.2. Ophthalmic

10.9.3. Dermal Fillers

10.9.4. Vesicoureteral Reflux

10.10. Drivers and Restraints: Impact Analysis

10.11. Market Attractiveness Analysis

10.11.1. By Country

10.11.2. By Product Type

10.11.3. By Application

10.12. Key Representative Market Participants

10.13. Key Participants Market Presence (Intensity Map)

11. Forecast Factors: Relevance and Impact

12. Forecast Assumptions

13. Competition Landscape

13.1. Competition Dashboard

13.2. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)

13.2.1. Allergan plc

13.2.2. Anika Therapeutics Inc.

13.2.3. Shanghai Jingfeng Pharmaceutical Co., Ltd.

13.2.4. Ferring Pharmaceuticals

13.2.5. Galderma SA (Nestle Skin Health Company)

13.2.6. Sanofi

13.2.7. Salix Pharmaceuticals Ltd. (Sub. Valeant)

13.2.8. Smith & Nephew

13.2.9. Zimmer Biomet

13.2.10. Seikagaku Corporation

13.2.11. Fidia Farmaceutici s.p.a.

14. Global Hyaluronic Acid Products Market Analysis 2012–2016 and Forecast 2017–2027 By Region

14.1. Introduction / Key Findings

14.2. Historical Market Size (US$ Mn) Analysis By Region, 2012-2016

14.2.1. North America

14.2.2. Latin America

14.2.3. Western Europe

14.2.4. Eastern Europe

14.2.5. Japan

14.2.6. Asia Pacific Excluding Japan

14.2.7. Middle East and Africa

14.3. Market Size (US$ Mn) Forecast By Region, 2017-2027

14.3.1. North America

14.3.2. Latin America

14.3.3. Western Europe

14.3.4. Eastern Europe

14.3.5. Japan

14.3.6. Asia Pacific Excluding Japan

14.3.7. Middle East and Africa

14.4. Market Attractiveness Analysis By Region

15. Global Hyaluronic Acid Products Market Analysis 2012–2016 and Forecast 2017–2027, By Product Type

15.1. Introduction/Key Finding

15.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016

15.2.1. Single Cycle Injection Products

15.2.2. Three Cycle Injection Products

15.2.3. Five Cycle Injection Products

15.3. Market Size (US$ Mn) Forecast By Product Type, 2017-2027

15.3.1. Single Cycle Injection Products

15.3.2. Three Cycle Injection Products

15.3.3. Five Cycle Injection Products

15.4. Market Attractiveness Analysis By Product Type

16. Global Hyaluronic Acid Products Market Analysis 2012–2016 and Forecast 2017–2027, By Application

16.1. Introduction/Key Finding

16.2. Historical Market Size (US$ Mn) Analysis By Application, 2012-2016

16.2.1. Osteoarthritis

16.2.2. Ophthalmic

16.2.3. Dermal Fillers

16.2.4. Vesicoureteral Reflux

16.3. Market Size (US$ Mn) Forecast By Application, 2017-2027

16.3.1. Osteoarthritis

16.3.2. Ophthalmic

16.3.3. Dermal Fillers

16.3.4. Vesicoureteral Reflux

16.4. Market Attractiveness Analysis By Application

17. Global Hyaluronic Acid Products Market Analysis 2012–2016 and Forecast 2017–2027

17.1. Market Size and Y-o-Y Growth

17.2. Absolute $ Opportunity

17.3. Value Chain 

18. Assumptions and Acronyms Used

19. Research Methodology

Hyaluronic Acid Products Market Reports - List of Tables

Table 01 : North America Hyaluronic Acid Products Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country

Table 02 : North America Hyaluronic Acid Products Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Product Type Segment

Table 03 : North America Hyaluronic Acid Products Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Application Segment

Table 04 : Latin America Hyaluronic Acid Products Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country

Table 05 : Latin America Hyaluronic Acid Products Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Product Type Segment

Table 06 : Latin America Hyaluronic Acid Products Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Application Segment

Table 07 : Western Europe Hyaluronic Acid Products Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country

Table 08 : Western Europe Hyaluronic Acid Products Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Product Type Segment

Table 09 : Western Europe Hyaluronic Acid Products Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Application Segment

Table 10 : Eastern Europe Hyaluronic Acid Products Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country

Table 11 : Eastern Europe Hyaluronic Acid Products Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Product Type Segment

Table 12 : Eastern Europe Hyaluronic Acid Products Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Application Segment

Table 13 : APEJ Hyaluronic Acid Products Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, by Country

Table 14 : APEJ Hyaluronic Acid Products Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Product Type Segment

Table 15 : APEJ Hyaluronic Acid Products Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Application Segment

Table 16 : Japan Hyaluronic Acid Products Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Product Type Segment

Table 17 : Japan Hyaluronic Acid Products Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Application Segment

Table 18 : MEA Hyaluronic Acid Products Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country

Table 19 : MEA Hyaluronic Acid Products Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Product Type Segment

Table 20 : MEA Hyaluronic Acid Products Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Application Segment

Table 21 : Global Hyaluronic Acid Products Size (US$ Mn) Forecast by Region, 2012–2017

Table 22 : Global Hyaluronic Acid Products Size (US$ Mn) Forecast by Product Type, 2012–2017

Table 23 : Global Hyaluronic Acid Products Size (US$ Mn) Forecast by Application, 2012–2017

Hyaluronic Acid Products Market Reports - List of Figures

Figure 01 : North America Hyaluronic Acid Products Value Share By Product Type (2017)

Figure 02 : North America Hyaluronic Acid Products Value Share By Application (2017)

Figure 03 : North America Hyaluronic Acid Products Value Share By Country (2017)

Figure 04 : North America Hyaluronic Acid Products Forecast 2017 and 2027

Figure 05 : North America Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016

Figure 06 : North America Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 07 : North America Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Single Cycle Injection Products Segment

Figure 08 : North America Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Single Cycle Injection Products Segment

Figure 09 : North America Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Three Cycle Injection Products Segment

Figure 10 : North America Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Three Cycle Injection Products Segment

Figure 11 : North America Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Five Cycle Injection Products Segment

Figure 12 : North America Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Five Cycle Injection Products Segment

Figure 13 : North America Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Osteoarthritis Segment

Figure 14 : North America Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Osteoarthritis Segment

Figure 15 : North America Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Ophthalmic Segment

Figure 16 : North America Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Ophthalmic Segment

Figure 17 : North America Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Dermal Fillers Segment

Figure 18 : North America Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Dermal Fillers Segment

Figure 19 : North America Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Vesicoureteral Reflux Segment

Figure 20 : North America Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Vesicoureteral Reflux Segment

Figure 21 : North America Hyaluronic Acid Products Attractiveness Analysis, 2017–2027, by Product Type

Figure 22 : North America Hyaluronic Acid Products Attractiveness Analysis, 2017–2027, by Application 

Figure 23 : North America Hyaluronic Acid Products Attractiveness Analysis, 2017–2027, by Country

Figure 24 : Latin America Hyaluronic Acid Products Value Share By Product Type (2017)

Figure 25 : Latin America Hyaluronic Acid Products Value Share By Application (2017)

Figure 26 : Latin America Hyaluronic Acid Products Value Share By Country (2017)

Figure 27 : Latin America Hyaluronic Acid Products Forecast 2017 and 2027

Figure 28 : Latin America Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016

Figure 29 : Latin America Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 30 : Latin America Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Single Cycle Injection Products Segment

Figure 31 : Latin America Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Single Cycle Injection Products Segment

Figure 32 : Latin America Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Three Cycle Injection Products Segment

Figure 33 : Latin America Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Three Cycle Injection Products Segment

Figure 34 : Latin America Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Five Cycle Injection Products Segment

Figure 35 : Latin America Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Five Cycle Injection Products Segment

Figure 36 : Latin America Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Osteoarthritis Segment

Figure 37 : Latin America Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Osteoarthritis Segment

Figure 38 : Latin America Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Ophthalmic Segment

Figure 39 : Latin America Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Ophthalmic Segment

Figure 40 : Latin America Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Dermal Fillers Segment

Figure 41 : Latin America Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Dermal Fillers Segment

Figure 42 : Latin America Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Vesicoureteral Reflux Segment

Figure 43 : Latin America Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Vesicoureteral Reflux Segment

Figure 44 : Latin America Hyaluronic Acid Products Attractiveness Analysis, 2017–2027, by Product Type

Figure 45 : Latin America Hyaluronic Acid Products Attractiveness Analysis, 2017–2027, by Application 

Figure 46 : Latin America Hyaluronic Acid Products Attractiveness Analysis, 2017–2027, by Country

Figure 47 : Western Europe Hyaluronic Acid Products Value Share By Product Type (2017)

Figure 48 : Western Europe Hyaluronic Acid Products Value Share By Application (2017)

Figure 49 : Western Europe Hyaluronic Acid Products Value Share By Country (2017)

Figure 50 : Western Europe Hyaluronic Acid Products Forecast 2017 and 2027

Figure 51 : Western Europe Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016

Figure 52 : Western Europe Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 53 : Western Europe Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Single Cycle Injection Products Segment

Figure 54 : Western Europe Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Single Cycle Injection Products Segment

Figure 55 : Western Europe Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Three Cycle Injection Products Segment

Figure 56 : Western Europe Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Three Cycle Injection Products Segment

Figure 57 : Western Europe Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Five Cycle Injection Products Segment

Figure 58 : Western Europe Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Five Cycle Injection Products Segment

Figure 59 :  Western Europe Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Osteoarthritis Segment

Figure 60 : Western Europe Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Osteoarthritis Segment

Figure 61 : Western Europe Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Ophthalmic Segment

Figure 62 : Western Europe Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Ophthalmic Segment

Figure 63 : Western Europe Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Dermal Fillers Segment

Figure 64 : Western Europe Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Dermal Fillers Segment

Figure 65 : Western Europe Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Vesicoureteral Reflux Segment

Figure 66 : Western Europe Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Vesicoureteral Reflux Segment

Figure 67 : Western Europe Hyaluronic Acid Products Attractiveness Analysis, 2017–2027, by Product Type

Figure 68 : Western Europe Hyaluronic Acid Products Attractiveness Analysis, 2017–2027, by Application 

Figure 69 : Western Europe Hyaluronic Acid Products Attractiveness Analysis, 2017–2027, by Country

Figure 70 : Eastern Europe Hyaluronic Acid Products Value Share By Product Type (2017)

Figure 71 : Eastern Europe Hyaluronic Acid Products Value Share By Application (2017)

Figure 72 : Eastern Europe Hyaluronic Acid Products Value Share By Country (2017)

Figure 73 : Eastern Europe Hyaluronic Acid Products Forecast 2017 and 2027

Figure 74 : Eastern Europe Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016

Figure 75 : Eastern Europe Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 76 : Eastern Europe Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Single Cycle Injection Products Segment

Figure 77 : Eastern Europe Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Single Cycle Injection Products Segment

Figure 78 : Eastern Europe Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Three Cycle Injection Products Segment

Figure 79 : Eastern Europe Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Three Cycle Injection Products Segment

Figure 80 : Eastern Europe Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Five Cycle Injection Products Segment

Figure 81 : Eastern Europe Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Five Cycle Injection Products Segment

Figure 82 : Eastern Europe Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Osteoarthritis Segment

Figure 83 : Eastern Europe Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Osteoarthritis Segment

Figure 84 : Eastern Europe Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Ophthalmic Segment

Figure 85 : Eastern Europe Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Ophthalmic Segment

Figure 86 : Eastern Europe Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Dermal Fillers Segment

Figure 87 : Eastern Europe Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Dermal Fillers Segment

Figure 88 : Eastern Europe Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Vesicoureteral Reflux Segment

Figure 89 : Eastern Europe Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Vesicoureteral Reflux Segment

Figure 90 : Eastern Europe Hyaluronic Acid Products Attractiveness Analysis, 2017–2027, by Product Type

Figure 91 : Eastern Europe Hyaluronic Acid Products Attractiveness Analysis, 2017–2027, by Application 

Figure 92 : Eastern Europe Hyaluronic Acid Products Attractiveness Analysis, 2017–2027, by Country

Figure 93 : APEJ Hyaluronic Acid Products Value Share By Product Type (2017)

Figure 94 : APEJ Hyaluronic Acid Products Value Share By Application (2017)

Figure 95 : APEJ Hyaluronic Acid Products Value Share By Country (2017)

Figure 96 : APEJ Hyaluronic Acid Products Forecast 2017 and 2027

Figure 97 : APEJ Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016

Figure 98 : APEJ Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 99 : APEJ Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Single Cycle Injection Products Segment

Figure 100 : APEJ Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Single Cycle Injection Products Segment

Figure 101 : APEJ Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Three Cycle Injection Products Segment

Figure 102 : APEJ Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Three Cycle Injection Products Segment

Figure 103 : APEJ Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Five Cycle Injection Products Segment

Figure 104 : APEJ Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Five Cycle Injection Products Segment

Figure 105 : APEJ Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Osteoarthritis Segment

Figure 106 : APEJ Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Osteoarthritis Segment

Figure 107 : APEJ Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Ophthalmic Segment

Figure 108 : APEJ Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Ophthalmic Segment

Figure 109 : APEJ Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Dermal Fillers Segment

Figure 110 : APEJ Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Dermal Fillers Segment

Figure 111 : APEJ Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Vesicoureteral Reflux Segment

Figure 112 : APEJ Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Vesicoureteral Reflux Segment

Figure 113 : APEJ Hyaluronic Acid Products Attractiveness Analysis, 2017–2027, by Product Type

Figure 114 : APEJ Hyaluronic Acid Products Attractiveness Analysis, 2017–2027, by Application 

Figure 115 : APEJ Hyaluronic Acid Products Attractiveness Analysis, 2017–2027, by Country

Figure 116 : Japan Hyaluronic Acid Products Value Share By Product Type (2017)

Figure 117 : Japan Hyaluronic Acid Products Value Share By Application (2017)

Figure 118 : Japan Hyaluronic Acid Products Forecast 2017 and 2027

Figure 119 : Japan Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016

Figure 120 : Japan Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 121 : Japan Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Single Cycle Injection Products Segment

Figure 122 : Japan Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Single Cycle Injection Products Segment

Figure 123 : Japan Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Three Cycle Injection Products Segment

Figure 124 : Japan Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Three Cycle Injection Products Segment

Figure 125 : Japan Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Five Cycle Injection Products Segment

Figure 126 : Japan Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Five Cycle Injection Products Segment

Figure 127 : Japan Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Osteoarthritis Segment

Figure 128 : Japan Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Osteoarthritis Segment

Figure 129 : Japan Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Ophthalmic Segment

Figure 130 : Japan Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Ophthalmic Segment

Figure 131 : Japan Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Dermal Fillers Segment

Figure 132 : Japan Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Dermal Fillers Segment

Figure 133 : Japan Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Vesicoureteral Reflux Segment

Figure 134 : Japan Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Vesicoureteral Reflux Segment

Figure 135 : Japan Hyaluronic Acid Products Attractiveness Analysis, 2017–2027, by Product Type

Figure 136 : Japan Hyaluronic Acid Products Attractiveness Analysis, 2017–2027, by Application 

Figure 137 : MEA Hyaluronic Acid Products Value Share By Product Type (2017)

Figure 138 : MEA Hyaluronic Acid Products Value Share By Application (2017)

Figure 139 : MEA Hyaluronic Acid Products Value Share By Country (2017)

Figure 140 : MEA Hyaluronic Acid Products Forecast 2017 and 2027

Figure 141 : MEA Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016

Figure 142 : MEA Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 143 : MEA Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Single Cycle Injection Products Segment

Figure 144 : MEA Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Single Cycle Injection Products Segment

Figure 145 : MEA Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Three Cycle Injection Products Segment

Figure 146 : MEA Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Three Cycle Injection Products Segment

Figure 147 : MEA Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Five Cycle Injection Products Segment

Figure 148 : MEA Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Five Cycle Injection Products Segment

Figure 149 :  MEA Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Osteoarthritis Segment

Figure 150 : MEA Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Osteoarthritis Segment

Figure 151 : MEA Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Ophthalmic Segment

Figure 152 : MEA Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Ophthalmic Segment

Figure 153 : MEA Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Dermal Fillers Segment

Figure 154 : MEA Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Dermal Fillers Segment

Figure 155 : MEA Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Vesicoureteral Reflux Segment

Figure 156 : MEA Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Vesicoureteral Reflux Segment

Figure 157 : MEA Hyaluronic Acid Products Attractiveness Analysis, 2017–2027, by Product Type

Figure 158 : MEA Hyaluronic Acid Products Attractiveness Analysis, 2017–2027, by Application 

Figure 159 : MEA Hyaluronic Acid Products Attractiveness Analysis, 2017–2027, by Country

Figure 160 : Global Hyaluronic Acid Products Attractiveness Analysis by Region, 2017–2027 

Figure 161 : Global Hyaluronic Acid Products Attractiveness Analysis by Product Type, 2017–2027 

Figure 162 : Global Hyaluronic Acid Products Attractiveness Analysis by Application, 2017–2027 

Figure 163 : Global Hyaluronic Acid Products Value Analysis and Forecast, 2016–2027 (US$ Mn)

Figure 164 : Global Hyaluronic Acid Products Absolute $ Opportunity (US$ Mn), 2012–2016

Figure 165 : Global Hyaluronic Acid Products Absolute $ Opportunity (US$ Mn), 2016–2027